In this video, Professor Dr. Milan Latas explains that comorbidity in anxiety disorders is often under-recognized in routine clinical practice, which can obscure the true clinical picture. He emphasizes the importance of systematically asking about co-occurring substance use, depression, and personality disorders to secure an accurate diagnosis and guide care. With a proper diagnostic work-up, clinicians can plan treatment for both the primary anxiety disorder and any comorbid conditions; without it, multiple concurrent diagnoses—often two or more—can complicate the plan and even undermine outcomes. The talk also outlines how deliberate treatment planning grounded in good practice improves results, and when to choose medication, psychotherapy, or an integrated approach—noting that patients with comorbidities typically benefit from comprehensive, combined treatments.
Professor Dr. Milan Latas
Belgrade University School of Medicine and Clinic for Psychiatry, Clinical Center of Serbia
Related content
In the video, Professor Dr. Brenda Penninx highlights a significant increase in the prevalence of anxiety disorders, with a 50% rise over the last decade, affecting about 10% of the population.
In this video, Professor Dr. Dan Stein highlights the dynamic nature of anxiety disorders, emphasizing the need to re-conceptualize them from a course perspective.
In this video, Professor Dr. Milan Latas highlights the high prevalence of comorbidity in anxiety disorders, with 50% or more of patients having additional psychiatric conditions